⚕ GalenOps CRO console
← 714 (USA)

714-1035

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 714 (USA) (Dr. Clarke) · consented 2014-04-17
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate BRONCHITIS — outcome: RECOVERED/RESOLVED; onset 2014-07-18 (study day 93.0); relationship: NONE

mild assessed 2026-08-18

Mild BUNDLE BRANCH BLOCK RIGHT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-26 (study day 40.0); relationship: REMOTE

mild assessed 2026-08-18

Mild BUNDLE BRANCH BLOCK RIGHT — outcome: RECOVERED/RESOLVED; onset 2014-05-26 (study day 40.0); relationship: REMOTE

mild assessed 2026-08-18

Mild ELECTROCARDIOGRAM ST SEGMENT DEPRESSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-04 (study day 49.0); relationship: REMOTE

mild assessed 2026-08-18

Mild ELECTROCARDIOGRAM T WAVE INVERSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-26 (study day 40.0); relationship: REMOTE

mild assessed 2026-08-18

Mild SUPRAVENTRICULAR EXTRASYSTOLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-04 (study day 49.0); relationship: REMOTE

mild assessed 2026-08-18

Mild SUPRAVENTRICULAR EXTRASYSTOLES — outcome: RECOVERED/RESOLVED; onset 2014-06-04 (study day 49.0); relationship: REMOTE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.